Correlation Between Liaoning Chengda and Huaxia Eye

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Liaoning Chengda and Huaxia Eye at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liaoning Chengda and Huaxia Eye into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liaoning Chengda Biotechnology and Huaxia Eye Hospital, you can compare the effects of market volatilities on Liaoning Chengda and Huaxia Eye and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liaoning Chengda with a short position of Huaxia Eye. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liaoning Chengda and Huaxia Eye.

Diversification Opportunities for Liaoning Chengda and Huaxia Eye

0.98
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Liaoning and Huaxia is 0.98. Overlapping area represents the amount of risk that can be diversified away by holding Liaoning Chengda Biotechnology and Huaxia Eye Hospital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Huaxia Eye Hospital and Liaoning Chengda is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liaoning Chengda Biotechnology are associated (or correlated) with Huaxia Eye. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Huaxia Eye Hospital has no effect on the direction of Liaoning Chengda i.e., Liaoning Chengda and Huaxia Eye go up and down completely randomly.

Pair Corralation between Liaoning Chengda and Huaxia Eye

Assuming the 90 days trading horizon Liaoning Chengda Biotechnology is expected to generate 0.81 times more return on investment than Huaxia Eye. However, Liaoning Chengda Biotechnology is 1.23 times less risky than Huaxia Eye. It trades about -0.26 of its potential returns per unit of risk. Huaxia Eye Hospital is currently generating about -0.51 per unit of risk. If you would invest  2,645  in Liaoning Chengda Biotechnology on October 25, 2024 and sell it today you would lose (165.00) from holding Liaoning Chengda Biotechnology or give up 6.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.45%
ValuesDaily Returns

Liaoning Chengda Biotechnology  vs.  Huaxia Eye Hospital

 Performance 
       Timeline  
Liaoning Chengda Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Liaoning Chengda Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Huaxia Eye Hospital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Huaxia Eye Hospital has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Liaoning Chengda and Huaxia Eye Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Liaoning Chengda and Huaxia Eye

The main advantage of trading using opposite Liaoning Chengda and Huaxia Eye positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liaoning Chengda position performs unexpectedly, Huaxia Eye can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Huaxia Eye will offset losses from the drop in Huaxia Eye's long position.
The idea behind Liaoning Chengda Biotechnology and Huaxia Eye Hospital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital